Economics of Using Biocidal Surfaces - Use of Biocidal Surfaces for Reduction of Healthcare Acquired Infections - page 177

Table 8.5 Epidemiological data of the ICU patients

Preliminary pilot results for a time
period of 3 months. Thirty-seven
incidents relating to the period A
(before) and 32 incidents relating to
the period B (after) were studied

Before After

No. of patients 37 32

Male 22 19

Female 15 13

Age 73.36 74.34 NS

APAII 27.17 27.15 NS

SAPSII 55.19 53.41 NS

Days of hospitalization 13 10 NS

Consumption of
antibiotics (dose)
per patient per day

7.28 5.27

P = 0.014 SPSS18

NS: non statistically significant

Fig. 8.5 “Age distribution”

8.4.1 APACHE II Score

Parameters recorded and severity score calculated, for patients treated in the ICU
(during the first 24 h), using the APACHE II, showed no significant difference
between patients hospitalized during the period A (before) and those hospitalized
during the period B (after). Below is a graphic display of this observation.